Pain & Addiction XV Program Schedule


Schedule

  • 8:00 am – 8:15 am

    Welcome/Introductions
    Moderators:  Herbert L. Malinoff, MD, FACP, DFASAM, (Course Chair); R. Corey Waller, MD, MS, FACEP, (Course Vice Chair) 

    8:15 am – 9:00 am

    Buprenorphine Basics—Molecular Mechanisms, Neurobiology, and Pharmacokinetics/Dynamics
    Robert B. Raffa, PhD 

    9:00 AM – 9:30 am

    From Opium to Buprenorphine—Historical Overview of Analgesic Development, Risks, Benefits, and an Addiction Medicine Perspective
    Howard G. Kornfeld, MD, DFASAM

    9:30 am – 10:15 am

    Buprenorphine Clinical Research & Practice—An International Perspective with a Focus on the Evidence of Opioid Efficacy in U.S. Pain Medicine Practice
    Joseph Pergolizzi, Jr., MD

    10:15 am – 10:30 am

    Refreshment Break

    10:30 am – 11:15 am

    Buprenorphine and Therapeutic Strategies for the Super-Utilizer and Opioid-Induced Hyperalgesia
    Herbert L. Malinoff, MD, FACP, DFASAM and R. Corey Waller, MD, MS, FACEP 

    11:15 am – 12:15 pm

    Marijuana And Pain Medicine:  How to Have the Conversation with Your Chronic Pain Patient
     
    Mark A. Weiner, MD with Herbert L. Malinoff, MD, FACP, DFASAM, R. Corey Waller, MD, MS, FACEP and Melvin I. Pohl, MD, DFASAM 

    12:15 pm – 12:30 pm

    Morning Summary, Questions & Lunch Instructions
    Moderator:  Herbert L. Malinoff, MD, FACP, DFASAM 

    12:30 pm – 1:30 pm

    Lunch Break (On Your Own)

    1:30 pm – 2:00 pm

    Perioperative Buprenorphine, Hospitalized Patients, and Butrans- (Transdermal Buprenorphine) Assisted Opioid Rotation to Sublingual Buprenorphine
    Howard G. Kornfeld, MD, DFASAM with Herbert L. Malinoff, MD, FACP, DFASAM and R. Corey Waller, MD, MS, FACEP 

    2:00 pm – 2:45 pm

    Pregnant Patients
    Carl Christensen, MD, PhD, FACOG, CRMO, ABAM 

    2:45 pm – 3:30 pm

    Benzos and Buprenorphine
    Steven A. Wyatt, DO with Herbert L. Malinoff, MD, FACP, DFASAM and R. Corey Waller, MD, MS, FACEP 

    3:30 pm – 3:45 pm

    Refreshment Break

    3:45 pm – 4:30 pm

    Integration of Pharmacological Treatment with 12-Step Programs or Non-Pharmacological Treatment Alternatives
    Mevin I. Pohl, MD, DFASAM, Howard C. Wetsman, MD, DFASAM 

    4:30 pm – 5:15 pm

    Panel Discussion:  What’s Ahead for Buprenorphine & Audience Questions
    Moderators:  Herbert L. Malinoff, MD, FACP, DFASAM and R. Corey Waller, MD, MS, FACEP
    Panel:  Course Faculty

    5:15 pm – 5:30 pm

    Closing Remarks & Evaluation
    Moderators:  Herbert L. Malinoff, MD, FACP, DFASAM and R. Corey Waller, MD, MS, FACEP